Psoriasis is a skin disease characterised by inflammation and scaly lesions of the skin affecting 2-3% of the population in Europe and North America. Several different therapies are currently being used to treat psoriasis, but they all have the possibility of serious side effects. Additionally, they are expensive to produce and lack efficacy in some patients.
Researchers at the University of Strathclyde have isolated a novel compound for the treatment of psoriasis from a plant extract of Calendula officinalis (marigold). The compound has anti-proliferative effects against normal skin cells growing in tissue culture and has cleared initial regulatory toxicology testing. The compound can be applied locally to affected areas of the skin, thereby minimising the chances of systemic side effects.
· Topical application
· Regulatory toxicology data available
· Derived from clinically proven natural product
· Active compound can be synthesised chemically
· Novel mechanism of action
· Economical manufacture
Markets and Applications
This compound could be applied topically to affected areas of the skin for the treatment of psoriasis.
Contact is welcomed from parties interested in this project.